A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Granisetron
Carfentanil, C-11
The risk or severity of adverse effects can be increased when Vecuronium is combined with Carfentanil, C-11.
Granisetron
Tilidine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Tilidine.
Granisetron
Phenazocine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Phenazocine.
Granisetron
Phenoperidine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Phenoperidine.
Granisetron
Meptazinol
The risk or severity of adverse effects can be increased when Vecuronium is combined with Meptazinol.
Granisetron
Alphaprodine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Alphaprodine.
Granisetron
Piritramide
The risk or severity of adverse effects can be increased when Vecuronium is combined with Piritramide.
Granisetron
Normethadone
The risk or severity of adverse effects can be increased when Vecuronium is combined with Normethadone.
Granisetron
Opium
The risk or severity of adverse effects can be increased when Vecuronium is combined with Opium.
Granisetron
Lofentanil
The risk or severity of adverse effects can be increased when Vecuronium is combined with Lofentanil.
Granisetron
DPDPE
The risk or severity of adverse effects can be increased when Vecuronium is combined with DPDPE.
Granisetron
Ketobemidone
The risk or severity of adverse effects can be increased when Vecuronium is combined with Ketobemidone.
Granisetron
Dihydromorphine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Dihydromorphine.
Granisetron
Alphacetylmethadol
The risk or severity of adverse effects can be increased when Vecuronium is combined with Alphacetylmethadol.
Granisetron
Dihydrocodeine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Dihydrocodeine.
Granisetron
Carfentanil
The risk or severity of adverse effects can be increased when Vecuronium is combined with Carfentanil.
Granisetron
Desomorphine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Desomorphine.
Granisetron
Dextromoramide
The risk or severity of adverse effects can be increased when Vecuronium is combined with Dextromoramide.
Granisetron
Etorphine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Etorphine.
Granisetron
Ethylmorphine
The risk or severity of adverse effects can be increased when Vecuronium is combined with Ethylmorphine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3